| __timestamp | Corcept Therapeutics Incorporated | Teva Pharmaceutical Industries Limited |
|---|---|---|
| Wednesday, January 1, 2014 | 18372000 | 1488000000 |
| Thursday, January 1, 2015 | 15419000 | 1525000000 |
| Friday, January 1, 2016 | 23844000 | 2111000000 |
| Sunday, January 1, 2017 | 40376000 | 1848000000 |
| Monday, January 1, 2018 | 75247000 | 1213000000 |
| Tuesday, January 1, 2019 | 89017000 | 1010000000 |
| Wednesday, January 1, 2020 | 114764000 | 997000000 |
| Friday, January 1, 2021 | 113864000 | 967000000 |
| Saturday, January 1, 2022 | 130991000 | 838000000 |
| Sunday, January 1, 2023 | 184353000 | 953000000 |
| Monday, January 1, 2024 | 998000000 |
Unlocking the unknown
In the ever-evolving pharmaceutical industry, research and development (R&D) is the lifeblood of innovation. Over the past decade, Teva Pharmaceutical Industries Limited and Corcept Therapeutics Incorporated have demonstrated contrasting approaches to R&D investment.
Teva, a global leader, has consistently allocated substantial resources to R&D, peaking in 2016 with a budget that was nearly 90% higher than Corcept's. However, Teva's R&D spending has seen a gradual decline, dropping by approximately 55% from 2016 to 2023. In contrast, Corcept, a smaller player, has steadily increased its R&D budget, achieving a remarkable 900% growth from 2014 to 2023.
This divergence highlights the strategic differences between a large, established company and a nimble, growth-focused firm. As the pharmaceutical landscape continues to shift, these R&D trends offer valuable insights into the future trajectories of these industry players.
Analyzing R&D Budgets: Bristol-Myers Squibb Company vs Teva Pharmaceutical Industries Limited
Research and Development Expenses Breakdown: Teva Pharmaceutical Industries Limited vs Dr. Reddy's Laboratories Limited
R&D Insights: How Teva Pharmaceutical Industries Limited and Ascendis Pharma A/S Allocate Funds
Research and Development Investment: Biogen Inc. vs Corcept Therapeutics Incorporated
Research and Development Investment: United Therapeutics Corporation vs Corcept Therapeutics Incorporated
Research and Development Investment: Viatris Inc. vs Corcept Therapeutics Incorporated
Exelixis, Inc. or Corcept Therapeutics Incorporated: Who Invests More in Innovation?
Who Prioritizes Innovation? R&D Spending Compared for Halozyme Therapeutics, Inc. and Corcept Therapeutics Incorporated
R&D Insights: How Pharming Group N.V. and Corcept Therapeutics Incorporated Allocate Funds
Who Prioritizes Innovation? R&D Spending Compared for Grifols, S.A. and Corcept Therapeutics Incorporated
R&D Insights: How Corcept Therapeutics Incorporated and ImmunityBio, Inc. Allocate Funds
R&D Insights: How Corcept Therapeutics Incorporated and Supernus Pharmaceuticals, Inc. Allocate Funds